Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Renovaro Appoints Nathen Fuentes as Chief Financial Officer Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth...
Renovaro Issues Shareholder Letter and Provides Corporate Update Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc...
Renovaro to Acquire Predictive Oncology in All-Stock Transaction Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology...
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV Current Renovaro Chairman to Lead Subsidiary’s Development Program and Commercialization LOS ANGELES and AMSTERDAM, Dec. 30, 2024...
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program LUMINA is an Advanced Minimal Residual Disease Detection Platform for Lung Cancer Harnessing the Power of...
Renovaro Regains Compliance with NASDAQ Listing Requirement LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered...
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection Renovaro will Establish the GEDi CUBE Next Generation Nvidia Blackwell Cluster...
Renovaro Issues Shareholder Letter and Provides Corporate Update LOS ANGELES, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics...
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in...
Renovaro Announces Strategic Restructuring and Leadership Transition Supermajority of Shareholders Support Appointment of New CEO and the Replacement of Entire Board of Directors with Full...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.04 | 5.36193029491 | 0.746 | 1.046 | 0.746 | 376 | 1.00176995 | DE |
| 4 | -0.814 | -50.875 | 1.6 | 1.83 | 0.746 | 819 | 1.37955561 | DE |
| 12 | 0.164 | 26.3665594855 | 0.622 | 1.83 | 0.468 | 1246 | 1.11928051 | DE |
| 26 | -0.648 | -45.1882845188 | 1.434 | 1.83 | 0.3995 | 2120 | 0.77995862 | DE |
| 52 | -3.254 | -80.5445544554 | 4.04 | 4.3 | 0.3995 | 2165 | 1.28268106 | DE |
| 156 | -2.274 | -74.3137254902 | 3.06 | 4.88 | 0.3995 | 1759 | 1.77429047 | DE |
| 260 | -2.274 | -74.3137254902 | 3.06 | 4.88 | 0.3995 | 1759 | 1.77429047 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
